Reversible long-acting contraceptives

Journal of the American Osteopathic Association

Volumn 97, Issue 8 SUPPL. 1, 1997, Pages

  Delvadia, Dipak ^a  

^a Sandwich Community Hospital   (United States)

Author keywords

Birth control; Contraception; Depot medroxyprogesterone acetate; Intrauterine device; Levonorgestrel subdermal implant system

Indexed keywords

EID: 28144459693     PISSN: 00986151     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Klitsch M: Injectable hormones and regulatory controversy: An end to the long-running story? Fam Plann Perspect 1993;25:37-41.
2. Jordan A: Toxicology of depot medroxyprogesterone acetate. Contraception 1994;49:189-201.
3. Tafelski T, Bochm KE: Contraceptives in adolescent patient. Prim Care Clin 1995;22:145-159.
4. Mishell DR Jr: Pharmacokinetics of depot medroxyprogesterone acetate contraception. J Reprod Med 1996;41:381-386.
5. Trussel J, Kost K: Contraceptive failure in the U.S. Stud Fam Plann 1987;18237-342.
6. Kaunitz M, Jordan CW: Two long-acting hormonal contraceptive options. Cont Obstet Gynecol 1997;42(2):27-50.
7. Pardthaisong T, Yenchit C, Gary R: The long-term growth and development of children exposed to Depo-Provera during pregnancy or lactation. Contraception 1992;43:313-318.
8. Westhoff C: Depot medroxyprogesterone acetate contraception: Metabolic parameter and mood changes. J Reprod Med 1996;41:401-405.
9. The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives: A multinational study. Lancet 1991;1:833-841.
10. Kaunitz AM: DMPA and the risk of breast and gynecologic cancer. J Reprod Med 1996;41:419-423.
11. Cullins VE: Noncontraceptive benefits and therapeutic use of DMPA. J Reprod Med 1996;41:428-433.
12. Davis AJ: Use of depot medroxyprogesterone acetate in adolescents. J Reprod Med 1996;41:407-414.
13. Kaunitz AM: Long-acting injectable contraception with DMPA. Am J Obstet Gynecol 1994;170:1543-1549.
14. The Upjohn Company, Kalamazoo, Mich. Prescribing information. October 1992.
15. Diaz S, Croxatto HB, Pavez M, et al: Clinical assessment of treatments for prolonged bleeding in users of Norplant implants. Contraception 1990;42:97-101.
16. Brache V, Alvarez-Sanchez F, Faundes A, et al: Ovarian endocrine function through five years of continuous treatment with Norplant subdermal contraceptive implants. Contraception 1990;41:169-173.
17. Sivin I: International experience with Norplant and Norplant-2 contraceptives. Stud Fam Plann 1988;19:81-88.
18. Shoup D, Mishell DR Jr. Bopp B, et al: The significance of bleeding patterns in Norplant implant users. Obstet Gynecol 1991;22:248-262.
19. Class-action suits filed against Norplant manufacturer. Contraceptive Technology Update 1991;7:389-394.
20. Weiner HM, DiMarcangelo MT, Heim JA, Prindpato R: Use of computed tomography guidance and mammographic hook wires to remove displaced, embedded contraceptive rods. JAOA 1996;96:422-423.
21. Cecil H, Reed D, Holtz J: Norplant removal facilitated by use of ultrasound for localization. J Fam Pract 1995;40:182-183.
22. Rosenberg MJ, Alvarez F, Barone MA, et al: A comparison of "U" and standard techniques for Norplant removal. Obstet Gynecol 1997;89:168-173.
23. Sivin I, Viegas O, Campodonico I, et al: Clinical performance of the new two implant system vs Norplant: A three year randomized study. In press.
24. Tatum HJ: Milestones in IUD development. Fertil Steril 1983;39:141-149.
25. Srvin I, Stern J, International Committee for Contraception Research: Health during prolonged use of levonorgestrel 20μg/d and the copper TCu 380 Ag IUD: A multicenter study. Fertil Steril 1994;61:70-79.
26. Alvarez F, Branche V, Fernandez E, et al: New insights on the mode of action of intrauterine devices in women. Fertil Steril 1988;49:768-773.
27. Ammalan M, Nyman T, Strengell L, et al: Effect of intrauterine contraceptive devices on cytokine messenger ribonucleic acid expression in the human endometrium. Fertil Steril 1995;63:773-778.
28. Sivin I, Schmidt F: Effectiveness of IUDs: A review. Contraception 1987;36:55-63.
29. Speroff L, Glass RH, Kase NG: Clinical Gynecologic Endocrinology and Infertility, ed 5. Baltimore, Md, Williams & Wilkins, 1994, p 740.
30. Chi C: A bill of health for the IUD: Where do we go from here? Advances in Contraception 1994;10(2):121-123.